Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Taryn Joyce

Registered Nurse, Psychiatric/Mental Health, Adult San Pedro, CA Nurse Practitioner

NPI 1235787235 CMS profile 11204505

150 W 7Th St, San Pedro, CA 90731

Open in the dashboard

General payments

$3,817

103 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Taryn Joyce of San Pedro, CA is reported in the CMS Open Payments database as having received $3,817 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Registered Nurse, Psychiatric/Mental Health, Adult profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,925 65
2024 General $834 22
2023 General $918 13
2022 General $141 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Taryn Joyce
  • Registered Nurse, Psychiatric/Mental Health, Adult median
  • Middle half of Registered Nurse, Psychiatric/Mental Health, Adult
  • National median

In program year 2025, general payments to Taryn Joyce were reported at $1,925. Among 96 Registered Nurse, Psychiatric/Mental Health, Adult profiles paid that year, the median was $121 and the middle half received between $39 and $265.

Show as a table
Year Taryn Joyce Registered Nurse, Psychiatric/Mental Health, Adult median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $108 $31–$328 $132
2022 $141 $99 $22–$306 $149
2023 $918 $99 $43–$313 $160
2024 $834 $119 $30–$319 $164
2025 $1,925 $121 $39–$265 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Otsuka America Pharmaceutical, Inc. $995 17 payments
  2. ITI, Inc. $642 21 payments
  3. AbbVie, Inc. $517 27 payments
  4. Vanda Pharmaceuticals Inc. $413 8 payments
  5. Teva Pharmaceuticals USA, Inc. $390 4 payments
  6. Janssen Pharmaceuticals, Inc $329 10 payments
  7. Alkermes, Inc. $151 3 payments
  8. Regeneron Healthcare Solutions, Inc. $122 1 payment
  9. Axsome Therapeutics, Inc. $85 4 payments
  10. Neurocrine Biosciences, Inc. $56 2 payments
  11. Other $117 6 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $3,817 103 payments
Products named General payments · program years 2022–2025
  1. REXULTI $595 10 payments
  2. FANAPT $413 8 payments
  3. ABILIFY MAINTENA $400 7 payments
  4. CAPLYTA Psychiatry $395 11 payments
  5. ABILIFY ASIMTUFII $278 5 payments
  6. UZEDY $270 3 payments
  7. VRAYLAR Neuroscience $261 9 payments
  8. VRAYLAR Neuroscience $256 18 payments
  9. CAPLYTA Psychiatry $248 10 payments
  10. INVEGA SUSTENNA $217 6 payments
  11. Other $1,388 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Registered Nurse, Psychiatric/Mental Health, Adult in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record